Patient Capital Management’s DXC Technology DXC Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-1,198,173
| Closed | -$25M | – | 44 |
|
2023
Q3 | $25M | Buy |
1,198,173
+1,095,323
| +1,065% | +$22.8M | 1.46% | 30 |
|
2023
Q2 | $2.75M | Buy |
102,850
+42,850
| +71% | +$1.14M | 0.15% | 36 |
|
2023
Q1 | $1.53M | Sell |
60,000
-100,600
| -63% | -$2.57M | 0.68% | 38 |
|
2022
Q4 | $4.26M | Sell |
160,600
-29,400
| -15% | -$779K | 2.07% | 25 |
|
2022
Q3 | $4.65M | Sell |
190,000
-81,600
| -30% | -$2M | 2.32% | 19 |
|
2022
Q2 | $8.23M | Sell |
271,600
-30,000
| -10% | -$909K | 3.65% | 7 |
|
2022
Q1 | $9.84M | Sell |
301,600
-22,100
| -7% | -$721K | 3.33% | 5 |
|
2021
Q4 | $10.4M | Buy |
+323,700
| New | +$10.4M | 3% | 4 |
|